Cancer Focus Fund - aVenture Asset Manager Research
Cancer Focus Fund
Operating Status: Operating
Cancer Focus Fund: A dedicated investment firm specializing in cancer-focused financial services.
Location
Shreveport, LA, US
Founded
2019
Cancer Focus Fund is an oncology-focused investment firm that specializes in supporting promising cancer therapies at or near the FDA Phase I or II human clinical trial stages. The firm typically invests in seed rounds and other early-stage funding opportunities. By concentrating on cancer treatments, Cancer Focus Fund aims to advance groundbreaking therapies through critical stages of development.
Notable portfolio companies include ImmunoGenesis and March Biosciences, which have raised $4.5 million and $4.8 million, respectively. The fund collaborates closely with The University of Texas MD Anderson Cancer Center, offering extensive business, management, IP, clinical, scientific, and regulatory support. Founded by Ross Barrett, the firm leverages a team of experienced professionals to provide comprehensive assistance to its portfolio companies.
Cancer Focus Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Current Portfolio Count2
Top Investment Stages
Seed1 (50.0%)
Series A1 (50.0%)
Stage Mix
Seed 50%Series A 50%
Concentration shown as share of disclosed investments by stage.
